Satellite Symposium on "Novel Strategies for Intervention in Neurodegenerative Di

“神经退行性疾病干预新策略”卫星研讨会

• 批准号: 7749492
• 负责人: GRACE Y SUN
• 金额: $ 4.9万
• 依托单位: UNIVERSITY OF MISSOURI-COLUMBIA
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-07-15 至 2010-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7749492
• 关键词: Address; Adult; Affect; Age; Aging; Alzheimer' s Disease; Area; Asia; Asians; Botanicals; Cause of Death; Cognitive; Collaborations; Dementia; Europe; Funding Applicant; Future; Goals; Health; Human; International; Intervention; Korea; Motor; Nerve Degeneration; Neurodegenerative Disorders; Parkinson Disease; Pharmaceutical Preparations; Prevalence; Public Health; Research; Research Personnel; Scientist; Societies; Solutions; Stroke; Taiwan; Therapeutic; Travel; Underrepresented Minority; Work; disability; interest; lectures; meetings; neurochemistry; novel; novel strategies; posters; public health relevance; symposium

DESCRIPTION (provided by applicant): Funding is requested for partial support of a satellite symposium entitled "Novel Interventional Strategies in Neurodegenerative Diseases" to be held in Taipei, Taiwan, August 30-September 2, 2009. This symposium is sponsored by the International Society for Neurochemistry (ISN)/Asian Pacific Society of Neurochemistry (APSN) which will be having the biannual meeting in Busan, Korea, August 23-29, 2009. The major goal for this symposium is to bring together international scientists to address a topic of immense importance to human health with special focus on intervention strategies on neurodegenerative diseases, with particular emphasis on Alzheimer's disease, Parkinson's disease and stroke. Scientific sessions will include intervention strategies targeting neurolipids, therapeutics for stroke, Alzheimer's disease, and other neurodegenerative diseases, and intervention through nutraceuticals and botanicals. This symposium is comprised of plenary lectures, presentations, posters and a discussion session to identify key issues and promising direction of future research. The symposium will provide opportunities for young scientists and underrepresented minorities to interact and exchange information with prominent neuroscientists and establish collaborations. More than 45 world renowned investigators from US, Europe, and Asia working in the neurodegeneration area have expressed interest in participating in this symposium and presenting their recent findings. This application seeks partial travel support for 30 US senior investigators and 10 junior and underrepresented minority investigators in US in order to provide opportunity to participate in this symposium. PUBLIC HEALTH RELEVANCE: The prevalence of neurodegenerative diseases especially, stroke, Alzheimer's and Parkinson's diseases will increase in the next decade. Stroke is the third leading cause of death in the US and the most common cause of disabilities in aging adults. Alzheimer's disease is the most common dementia affecting 4 million people in the US. In view of the fact that no conclusive evidence exists for long-lasting cognitive or motor improvement with the current drugs, the Public Health value of efficacious and safe solutions is apparent.

DESCRIPTION (provided by applicant): Funding is requested for partial support of a satellite symposium entitled "Novel Interventional Strategies in Neurodegenerative Diseases" to be held in Taipei, Taiwan, August 30-September 2, 2009. This symposium is sponsored by the International Society for Neurochemistry (ISN)/Asian Pacific Society of Neurochemistry (APSN) which will be having the 2009年8月23日至29日在韩国釜山举行的双年度会议。该研讨会的主要目的是将国际科学家汇集在一起​​，以解决对人类健康至关重要的话题，特别关注有关神经退行性疾病的干预策略，尤其强调了阿尔茨海默氏病，帕克森氏病和Stroke。科学会议将包括针对神经脂质的干预策略，中风治疗，阿尔茨海默氏病以及其他神经退行性疾病，以及通过营养素和植物学的干预。该研讨会由全体讲座，演讲，海报和讨论会议组成，以确定关键问题和未来研究的有希望的方向。研讨会将为年轻的科学家和代表性不足的少数群体提供与著名神经科学家交互和交流信息并建立合作的机会。来自美国，欧洲和亚洲在神经退行性地区工作的45多名世界知名的调查员表达了参与该研讨会并提出他们最近的发现的兴趣。该申请为美国30位美国高级调查员以及美国的10名初级和代表性不足的少数族裔调查员提供部分旅行支持，以便提供机会参加该研讨会。 公共卫生相关性：神经退行性疾病的患病率尤其是中风，阿尔茨海默氏症和帕金森氏症的疾病将在未来十年内增加。中风是美国的第三大死亡原因，也是老年人老龄化的残疾最常见原因。阿尔茨海默氏病是影响美国400万人的最常见痴呆症。鉴于目前的药物没有持久的认知或运动改善的结论性证据，因此有效和安全解决方案的公共健康价值显然是显而易见的。